Financhill
Sell
44

GANX Quote, Financials, Valuation and Earnings

Last price:
$3.21
Seasonality move :
19.87%
Day range:
$2.75 - $3.30
52-week range:
$1.41 - $4.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
18.89x
Volume:
1.2M
Avg. volume:
2M
1-year change:
104.49%
Market cap:
$111.6M
Revenue:
--
EPS (TTM):
-$0.64

Earnings Data

Next earnings date for GANX
--
Most recent earnings per share
-$0.15
Beat by $0.00
(Sep 30/2025)
Consensus Estimate
-$0.15
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 -- -- -- -$0.15 --
09/30/2025 Q3 -- -- -$0.15 -$0.15 $0.00
08/08/2025 Q2 -- -- -$0.19 -$0.17 -$0.02
05/14/2025 Q1 -- -- -$0.16 -$0.17 $0.01
03/27/2025 Q4 -- -- -$0.14 -$0.19 $0.05
11/14/2024 Q3 $6K -- -$0.17 -$0.21 $0.04
08/08/2024 Q2 $240K -- -$0.42 -$0.22 -$0.20
05/14/2024 Q1 $90K -- -$0.22 -$0.33 $0.11
03/26/2024 Q4 $260K -- -$0.29 -$0.34 $0.05
11/14/2023 Q3 -- -- -$0.37 -$0.46 $0.09
08/10/2023 Q2 -- -- -$0.62 -$0.38 -$0.24
05/12/2023 Q1 -- -- -$0.43 -$0.41 -$0.03
03/23/2023 Q4 -- -- -$0.39 -$0.36 -$0.03
11/11/2022 Q3 -- -- -$0.38 -$0.46 $0.08
08/08/2022 Q2 -- -- -$0.43 -$0.31 -$0.12
05/16/2022 Q1 -- -- -$0.28 -$0.37 $0.09
03/24/2022 Q4 -- -- -$0.26 -$0.49 $0.23
11/12/2021 Q3 -- -- -$0.39 -$0.34 -$0.06
08/11/2021 Q2 -- -- -$0.30 -$0.23 -$0.07
05/10/2021 Q1 -- -- -$0.50 -$0.13 -$0.37
12/31/2020 Q4 -- -- -$0.15 -- --
09/30/2020 Q3 -- -- -$0.14 -- --
06/30/2020 Q2 -- -- -$0.09 -- --
03/31/2020 Q1 -- -- -$0.10 -- --

Gain Therapeutics, Inc. Earnings Questions

  • How Much did Gain Therapeutics, Inc. Generate in Revenue Last Quarter?

    Gain Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Gain Therapeutics, Inc. Beat Earnings Last Quarter?

    Gain Therapeutics, Inc. announced earnings per share of -$0.15 which represents a beat of analyst forecast a -$0.15 per share.

  • Is Gain Therapeutics, Inc. Profitable?

    Gain Therapeutics, Inc. reported -$22.8K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Gain Therapeutics, Inc. EPS Next Year?

    Gain Therapeutics, Inc.'s earnings are forecast to decrease from -$0.89 per share to -$1.00 per share next year representing a decrease of -27.69%.

  • When is Gain Therapeutics, Inc.'s Earnings Date?

    Currently, Gain Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock